Boston University School of Medicine, United States of America
Addiction Science & Clinical Practice provides a forum for clinically relevant research and perspectives that contribute to improving the quality of care for people with unhealthy alcohol, tobacco, or other drug use and addictive behaviours across a spectrum of clinical settings.
Addiction Science & Clinical Practice was previously published by NIDA and the journal's back content can be viewed here.
The science of addiction is now robust. But the quality of care received by most people affected by unhealthy alcohol and other drug use (from risky use to dependence) and addictive behaviors is often much poorer than, and separated from, mainstream health care. This journal meets an important need—to disseminate high-quality, clinically relevant research that should lead to the high-quality care our patients deserve, particularly in general health-care settings.
Richard Saitz MD, MPH, FACP, FASAM, is a professor of medicine at Boston University School of Medicine and professor of epidemiology at Boston University School of Public Health. He directs the Clinical Addiction Research & Education (CARE) Unit and the Division of Clinical Research Resources of the Clinical Translational Science Institute at Boston Medical Center/Boston University School of Medicine, where he also serves as associate director of the Office of Clinical Research.
A primary care internist and a health services researcher certified by the American boards of addiction medicine and internal medicine, Dr. Saitz’s primary areas of expertise are screening and brief intervention for unhealthy alcohol and drug use, integrating substance-related and general health care (e.g., chronic disease/care management), and improving the quality of care for people with addictions across the spectrum of use, particularly in general medical care settings.
He is editor of Alcohol, Other Drugs and Health: Current Evidence, the author of over 100 peer-reviewed publications, immediate past president of the Association for Medical Education and Research in Substance Abuse (AMERSA), and former chairman of the BUSM/BMC Institutional Review Board. He has served on several Data Safety Monitoring Boards (including as Chairman) and is a member of a standing research review committee for the US National Institute on Alcohol Abuse and Alcoholism (NIAAA). His research has been supported by US National Institutes of Health, the Robert Wood Johnson Foundation, and the US Substance Abuse and Mental Health Services Administration/Center for Substance Abuse Prevention and Center for Substance Abuse Treatment ((SAMHSA/CSAT).